Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s448492 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2024. Verfasst von Kwang Yong Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeon…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Adrenergic beta-2 Receptor Agonists, Drug Costs, Databases, Factual. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Boehringer-Ingelheim Korea.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, Gyeonggi-do, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea.
- Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea.
- Respiratory, Medical Affairs, Boehringer-Ingelheim Korea, Seoul, Republic of Korea.
- Real-World Solutions, IQVIA Korea, Seoul, Republic of Korea.
ORCID-Profile: Kwang Yong Choi, Chin Kook Rhee, Kwang Ha Yoo, Yong Bum Park, Yong Il Hwang
Förderung
- Boehringer-Ingelheim Korea
Zitieren
APA
Choi, K. Y., Kim, H. I., Rhee, C. K., Yoo, K. H., Park, Y. B., Kim, Y., Lee, S. E., Kim, J. A., & Hwang, Y. I. (2024). Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s448492
Vancouver
Choi KY, Kim HI, Rhee CK, Yoo KH, Park YB, Kim Y, et al. Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s448492
BibTeX
@article{Choi2024,
author = {Choi, Kwang Yong and Kim, Hwan Il and Rhee, Chin Kook and Yoo, Kwang Ha and Park, Yong Bum and Kim, Youlim and Lee, So Eun and Kim, Jung-Ae and Hwang, Yong Il},
title = {Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s448492}
}
EUVIMED